TXNIP and Hyperglycemia: The thioredoxin-interacting protein, TXNIP, is induced in vivo by hyperglycemia and it inhibits the antioxidative function of thioredoxin resulting in accumulation of reactive oxygen species, cellular stress, and induction of the miR-200 family which induces apoptosis through inhibition of ZEB1.